Description: IMG-2005 acts as an inhibitor of the TLR signaling pathway by mimicking the Toll/interleukin-1 receptor (TIR) domain of MyD88. This action prevents the homodimerization of MyD88, mitigating damage to tracheal epithelial cells and averting the onset of pulmonary immune diseases.